Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

Clinical trial NCT04324125 · RECRUITING

Trial details

NCT number: NCT04324125
Sponsor: Hunan Province Tumor Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2020-03-24
Primary completion: 2024-12-24
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.